Many thanks to our instructors: Ralph Gonzales, Christopher Granger, Paul Hebert, Henry Lee, Matthew L. Maciejewski, Brook Martin, Leif Nelin, Susan L. Norris,J. Michael Oakes, Sean D. Sullivan, John P. Vavalle, David L. Veenstra
|Ralph Gonzales, MD, MSPH - Dr. Ralph Gonzales is a Professor in the Departments of Medicine and Epidemiology & Biostatistics at the University of California, San Francisco. He serves as the Director for the Program in Implementation and Dissemination Sciences and Associate Director for Clinical and Translational Sciences K12 Career Development Program. Dr. Gonzales received his MD at the University California, San Francisco, and MSPH from the University of Colorado Health Sciences Center, Denver, CO. His research interests include: management of acute respiratory tract infections, appropriate antibiotic use, diagnostic tests and clinical prediction rules, enhancing patient self-care, community-based health care interventions, physician behavior change models, and common symptom evaluation and unexplained symptoms. Dr. Gonzales plays a significant role in clinical and translational research training and career development at UCSF. He has designed an innovative approach to training in implementation and dissemination sciences.|
|Christopher Granger, MD - Dr. Granger is the Director of the Cardiac Care Unit at Duke University in Durham, NC. His research interests include critical care, general inpatient and outpatient cardiology, care of patients with acute and chronic ischemic heart disease, congestive heart failure, valvular heart disease, atrial fibrillation. He has led a number of large international clinical studies in heart attacks, unstable angina, heart failure, and atrial fibrillation. Dr. Granger is also the co-director of the Reperfusion of Acute MI in Carolina Emergency Departments (RACE) project, that is a North Carolina state-wide program to improve reperfusion care for acute myocardial infarction. He serves as the Chairman of the American Heart Association Mission: Lifeline program to improve heart attack care nationally as well as the American College of Cardiology/American Heart Association guideline committee for heart attack care.|
|Paul L. Hebert, PhD - Dr. Paul Hebert is a Research Associate Professor in the Department of Health Services at the University of Washington School of Public Health, and an Investigator in the VA Puget Sound Healthcare System Northwest Center for Outcome Research in Older Adults. He earned his PhD in Health Services Research in 2001 from the University of Minnesota, where he concentrated on research methods and health economics. Dr. Hebert teaches Advanced Health Services Research Methods in the PhD program in Health Services at University of Washington, and teaches comparative effectiveness research using Medicare data for the Centers for Medicare and Medicaid Services. As an Investigator at the VA, Hebert’s research is focused on comparative effectiveness and cost effectiveness research in kidney and cardiovascular diseases.|
|Henry Lee, MD - Dr. Henry Lee is an Assistant Clinical Professor of Pediatrics in the Division of Neonatology at the University of California, San Francisco. After graduating from the University of Illinois at Chicago College of Medicine, he completed a pediatrics residency, neonatology fellowship and an M.S. in epidemiology at Stanford University. He serves as Associate Director for Data Analysis for the California Perinatal Quality Care Collaborative (CPQCC), a quality improvement organization which includes 130 neonatal intensive care units. He is the recipient of a Clinical and Translational Science Institute Career Development Award at UCSF and the 2010 David Wirtschafter NICU Quality Improvement Award from the California Association of Neonatologists.|
|Matthew L. Maciejewski, PhD - Dr. Maciejewski is a Professor in the Division of General Internal Medicine, Department of Medicine at the Duke University Medical Center; a Research Career Scientist in the Center for Health Services Research in Primary Care at the Durham VA Medical Center; and an Adjunct Professor in the UNC Schools of Public Health and Pharmacy. With funding from RWJ HCFO, AHRQ, CMS and VA HSR&D, Matt has conducted quasi-experimental studies on the health and economic impacts of obesity and bariatric surgery, and randomized trials of self-management interventions for chronic disease management. He has also examined the impact of medication and visit copayments and Medicare managed care on patient outcomes. Matt is on the editorial board of Comparative Effectiveness Research. He received a doctorate in health services research from the University of Minnesota in 1998.|
|Brook Martin, PhD MPH - Dr. Martin is a member of the health services faculty at Dartmouth College and has a primary affiliation with the Department of Orthopaedics at Dartmouth-Hitchcock Medical Center. He earned his doctorate in Health Services from the School of Public Health and Community Medicine at the University of Washington with a dissertation involved examining variation in hospital and surgeon level reoperation rates following decompression operations for herniated disc, and describing the influence that practice volume has on reoperation rates.
Prior to his current position, Mr. Martin was affiliated with the Comparative Effectiveness, Costs and Outcomes Research Center (CECORC) at the University of Washington. He participated in studies involving spine conditions, including a longitudinal assessment of imaging and disability of the back, a prospective cohort study for the diagnosis and treatment of discogenic back pain, a randomized trial of rapid MRI versus X-ray for low back pain, and several secondary data analyses involving the epidemiology of spinal surgery and back problems.
Mr. Martin is an expert on analyzing administrative healthcare databases and has distinguished himself with several landmark publications in recent years concerning spinal care costs and rates of re-operation for lumbar spinal surgery. Most notable primary authorships include the "Expenditures and Health Status among adults with spine problems" (JAMA, 2008) and "Re-operations following Lumbar Spine Surgery and the Influence of Spinal Fusion Procedures" (Spine, 2006).
|Leif Nelin, MD - Dr. Nelin is the Division Chief of Neonatology at Nationwide Children’s Hospital and a Professor of Pediatrics at The Ohio State University College of Medicine. Clinically, Dr. Nelin is particularly interested in respiratory diseases, specifically in how pulmonary blood flow affects newborn respiratory diseases. Thus, persistent pulmonary hypertension of the newborn(PPHN) is one of his primary clinical interests. This has lead to his research interest in nitric oxide (NO), a potent vasodilator whose production is decreased in patients with PPHN. Utilizing cell culture techniques, isolated perfused lungs and animal preparations, Dr. Nelin studies the mechanisms that determine biological availability of the amino acid L-arginine on the ability of the lungs to produce NO and thereby regulate blood flow. The ultimate goal of this research is to understand the pathophysiology of PPHN and to develop new and specific therapies for the treatment of lung diseases that are characterized by alterations in NO production. A second area of research interest is the study of the developmental toxicology of inhaled NO.|
|Susan L. Norris, MD, MPH, MS - Dr. Norris is an Associate Professor in the Department of Medical Informatics and Clinical Epidemiology and the Department of Family Medicine at Oregon Health and Science University in Portland, Oregon. Dr. Norris received her MD and MSc in Experimental Surgery at the University of Alberta, Canada, and MPH from the University of Washington, Seattle, WA. She practiced primary care medicine at Group Health Cooperative of Puget Sound in Washington for nine years and then moved to the Centers for Disease Control and Prevention, where she led a systematic review work group within the Division of Diabetes. While at CDC, Dr. Norris published a number of widely-cited reviews on the effectiveness of diabetes education and weight control interventions for person with diabetes, including a number of Cochrane reviews. Prior to moving to Portland, Dr. Norris worked at the Agency for Healthcare Research and Quality (AHRQ) in Rockville, MD. At Oregon Health and Science University, her work focuses on systematic reviews, meta-analyses, and clinical practice guideline development. She performs systematic reviews and provides consultation on the processes of evidence retrieval, critical appraisal, and data synthesis for organizations including for the Drug Effectiveness Review Project of State Medicaid Agencies, the Agency for Healthcare Research and Quality in the US, and the Cochrane Collaboration.|
|J. Michael Oakes, PhD - Dr. Oakes is an Associate professor in the Division of Epidemiology and Community Health, University of Minnesota. He is Co-Executive Director of the Minnesota US Census Research Data Center and affiliated with the Minnesota Population Research Center. His professional interests center on quantitative methodology, social epidemiology and research ethics. In 1997 he earned a Ph.D. in sociology from the University of Massachusetts. Today he is an active researcher and frequent principal investigator on a wide variety of studies addressing a vast array of methodological, health, and ethical topics. Dr. Oakes has authored over 75 papers exploring problems at the intersection of social and medical sciences; his first text, entitled Methods in Social Epidemiology, was released in 2006 and has enjoyed wide praise. At UMN, he teaches several graduate-level courses in statistical methods and a Ph.D. seminar in social epidemiology. Finally, Dr. Oakes is involved with the RWJF obesity prevention programs and consults with a number of not-for-profit community organizations aiming to reduce health disparities among populations.|
|Sean D. Sullivan, BScPharm, MSc, PhD - Dr. Sullivan is Professor and Associate Dean for Research at the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health, is Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP) and co-Director of the University of Washington Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.
He completed his bachelor’s degree in pharmacy from Oregon State University in 1983, master’s degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.
Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions – the United States evidence-based guidelines for formulary decision-making.
Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.
|John P. Vavalle, MD - Dr. Vavalle attended medical school at UNC Chapel Hill and completed an Internal Medicine residency and chief residency at UNC Hospitals. He is currently a fourth-year fellow in cardiovascular medicine at Duke University Medical Center. Dr. Vavalle is completing a two-year clinical research fellowship at the Duke Clinical Research Institute and is participating in the Clinical Research Training Program (CRTP) which will lead to a Masters in Health Sciences degree. He will serve as Chief Fellow at the DCRI for the academic year 2011-2012.|
|David L. Veenstra, PhD - Dr. Veenstra is a Professor in the Pharmaceutical Outcomes Research and Policy Program in the Department of Pharmacy, and a member of the Institute for Public Health Genetics at the University of Washington in Seattle. He graduated from the University of California San Francisco, with doctoral degrees in clinical pharmacy and computational chemistry. He conducted his postdoctoral training in outcomes research with the University of Washington, including a one-year externship with Roche Global Pharmacoeconomics.
Dr. Veenstra’s primary research interests are the clinical, economic, and policy implications of using genomic information in healthcare. His major research projects include evaluation of warfarin pharmacogenomics, and decision modeling in breast and lung cancer to inform research prioritization and stakeholder decision making. Dr. Veenstra’s research is funded through grants from the Centers for Disease Control, National Cancer Institute, National Human Genome Research Institute, and the National Institute for General Medical Sciences. Dr. Veenstra is a member of EGAPP, a CDC-sponsored evidence-based recommendation group for genetic tests.
Dr. Veenstra’s other major research interest is the development of disease simulation models for chronic diseases. He has worked extensively with the Academy of Managed Care Pharmacy to develop guidelines and train decision makers in the practical application of cost-effectiveness models. Dr. Veenstra is an author or co-author of 100 peer-reviewed publications and five book chapters.